Privium Fund Management »

Tscan Therapeutics shares owned by Privium Fund Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Privium Fund Management from 13F filings

Historical chart of Privium Fund Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Privium Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Privium Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $127k 16k 8.01
2023-09-30 $42k 16k 2.62
2023-06-30 $40k 16k 2.53
2023-03-31 $41k 16k 2.59
2022-12-31 $25k 16k 1.55
2022-09-30 $48k 16k 3.03